Cargando…

PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway

P53 and DNA damage‐regulated gene1 (PDRG1) is overexpressed in diverse carcinomas. Here, we discover that PDRG1 is overexpressed in glioblastoma multiforme (GBM). However, the clinical significance, biological role, and underlying molecular mechanisms of PDRG1 in GBM remain unclear. PDRG1 was aberra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jinmin, Xu, Yixin, Liu, Jia, Cui, Huiyue, Cao, Haowei, Ren, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819344/ https://www.ncbi.nlm.nih.gov/pubmed/34812552 http://dx.doi.org/10.1111/cas.15214

Ejemplares similares

LRRC4 mediates the formation of circular RNA CD44 to inhibitGBM cell proliferation
por: Feng, Jianbo, et al.
Publicado: (2021)

MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway
por: Ren, Jing, et al.
Publicado: (2023)

BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway
por: Li, Huashun, et al.
Publicado: (2022)

The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases
por: Pérez, Claudia, et al.
Publicado: (2016)

PDRG1 at the interface between intermediary metabolism and oncogenesis
por: Pajares, María Ángeles
Publicado: (2017)

Correction: The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases
por: Pérez, Claudia, et al.
Publicado: (2016)

A pan-cancer analysis of the expression and prognostic significance of PDRG1
por: Liu, Zhen, et al.
Publicado: (2023)

Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway
por: Hou, Helei, et al.
Publicado: (2018)

The splicing activator DAZAP1 integrates splicing control into MEK/Erk regulated cell proliferation and migration
por: Choudhury, Rajarshi, et al.
Publicado: (2014)

Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
por: Zhang, Xiangchao, et al.
Publicado: (2023)

RASSF9 promotes NSCLC cell proliferation by activating the MEK/ERK axis
por: Yuan, Jun, et al.
Publicado: (2021)

Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma
por: Hu, Huanrong, et al.
Publicado: (2019)

Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma
por: Shigeoka, Manabu, et al.
Publicado: (2015)

KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway
por: Zhao, Hongda, et al.
Publicado: (2019)

KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway
por: Wang, Jie, et al.
Publicado: (2017)

TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway
por: Tang, Li, et al.
Publicado: (2023)

MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation
por: Pötschke, Rebecca, et al.
Publicado: (2020)

K-RAS Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation
por: Zhao, Yi, et al.
Publicado: (2021)

Role of MEK-ERK signaling mediated adhesion of glioma cells to extra-cellular matrix: Possible implication on migration and proliferation
por: Ramaswamy, Palaniswamy, et al.
Publicado: (2019)

Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway
por: Wei, Zhun, et al.
Publicado: (2023)

PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway
por: Cao, Huijun, et al.
Publicado: (2022)

BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma
por: Liu, Fen, et al.
Publicado: (2017)

Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S
por: Kong, Lingwei, et al.
Publicado: (2022)

The Potential Roles of the Apoptosis-Related Protein PDRG1 in Diapause Embryo Restarting of Artemia sinica
por: Zhang, Wan, et al.
Publicado: (2018)

Histidine-rich calcium binding protein promotes gastric cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition through Raf/MEK/ERK signaling
por: Wang, Chao, et al.
Publicado: (2022)

COPS3 Promotes Proliferation, Invasion, and EMT of Colorectal Cancer Cells by MEK/ERK Pathway
por: Xie, Yanchao, et al.
Publicado: (2022)

PD‐L1/PD‐L1 signalling promotes colorectal cancer cell migration ability through RAS/MEK/ERK
por: Cao, Yihui, et al.
Publicado: (2022)

Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway
por: Zeng, Zhou, et al.
Publicado: (2019)

Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
por: Wang, Yanshi, et al.
Publicado: (2020)

MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer
por: Wang, Jinfeng, et al.
Publicado: (2015)

Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway
por: Xing, Zhou, et al.
Publicado: (2016)

LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway
por: Liu, Jian, et al.
Publicado: (2020)

Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Publicado: (2021)

Long non-coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway
por: Yu, Xiaogang, et al.
Publicado: (2021)

MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover
por: Spiering, Désirée, et al.
Publicado: (2009)

CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis
por: Xie, Peiyi, et al.
Publicado: (2022)

Podoplanin Associates with CD44 to Promote Directional Cell Migration
por: Martín-Villar, Ester, et al.
Publicado: (2010)

Retraction: MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer
Publicado: (2020)

MAP3K8 Is a Prognostic Biomarker and Correlated With Immune Response in Glioma
por: Ren, Jing, et al.
Publicado: (2021)

Sensitivity of GBM cells to cAMP agonist-mediated apoptosis correlates with CD44 expression and agonist resistance with MAPK signaling
por: Daniel, Paul M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p4etrap1nvi6suhhh5llf0gddt